These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 32159364)
1. Comprehensive identification of signaling pathways for idiopathic pulmonary arterial hypertension. Liu B; Zhu L; Yuan P; Marsboom G; Hong Z; Liu J; Zhang P; Hu Q Am J Physiol Cell Physiol; 2020 May; 318(5):C913-C930. PubMed ID: 32159364 [TBL] [Abstract][Full Text] [Related]
2. DNA microarray and signal transduction analysis in pulmonary artery smooth muscle cells from heritable and idiopathic pulmonary arterial hypertension subjects. Yu J; Wilson J; Taylor L; Polgar P J Cell Biochem; 2015 Mar; 116(3):386-97. PubMed ID: 25290246 [TBL] [Abstract][Full Text] [Related]
3. A novel channelopathy in pulmonary arterial hypertension. Ma L; Roman-Campos D; Austin ED; Eyries M; Sampson KS; Soubrier F; Germain M; Trégouët DA; Borczuk A; Rosenzweig EB; Girerd B; Montani D; Humbert M; Loyd JE; Kass RS; Chung WK N Engl J Med; 2013 Jul; 369(4):351-361. PubMed ID: 23883380 [TBL] [Abstract][Full Text] [Related]
13. Tadalafil induces antiproliferation, apoptosis, and phosphodiesterase type 5 downregulation in idiopathic pulmonary arterial hypertension in vitro. Yamamura A; Fujitomi E; Ohara N; Tsukamoto K; Sato M; Yamamura H Eur J Pharmacol; 2017 Sep; 810():44-50. PubMed ID: 28603047 [TBL] [Abstract][Full Text] [Related]
14. Dihydropyridine Ca(2+) channel blockers increase cytosolic [Ca(2+)] by activating Ca(2+)-sensing receptors in pulmonary arterial smooth muscle cells. Yamamura A; Yamamura H; Guo Q; Zimnicka AM; Wan J; Ko EA; Smith KA; Pohl NM; Song S; Zeifman A; Makino A; Yuan JX Circ Res; 2013 Feb; 112(4):640-50. PubMed ID: 23300272 [TBL] [Abstract][Full Text] [Related]
15. Increased smooth muscle cell expression of caveolin-1 and caveolae contribute to the pathophysiology of idiopathic pulmonary arterial hypertension. Patel HH; Zhang S; Murray F; Suda RY; Head BP; Yokoyama U; Swaney JS; Niesman IR; Schermuly RT; Pullamsetti SS; Thistlethwaite PA; Miyanohara A; Farquhar MG; Yuan JX; Insel PA FASEB J; 2007 Sep; 21(11):2970-9. PubMed ID: 17470567 [TBL] [Abstract][Full Text] [Related]
16. Molecular Analysis of BMPR2, TBX4, and KCNK3 and Genotype-Phenotype Correlations in Spanish Patients and Families With Idiopathic and Hereditary Pulmonary Arterial Hypertension. Navas P; Tenorio J; Quezada CA; Barrios E; Gordo G; Arias P; López Meseguer M; Santos-Lozano A; Palomino Doza J; Lapunzina P; Escribano Subías P Rev Esp Cardiol (Engl Ed); 2016 Nov; 69(11):1011-1019. PubMed ID: 27453251 [TBL] [Abstract][Full Text] [Related]
17. Transcriptomic analysis of pulmonary artery smooth muscle cells identifies new potential therapeutic targets for idiopathic pulmonary arterial hypertension. Gorr MW; Sriram K; Muthusamy A; Insel PA Br J Pharmacol; 2020 Aug; 177(15):3505-3518. PubMed ID: 32337710 [TBL] [Abstract][Full Text] [Related]
18. A burden of rare variants in BMPR2 and KCNK3 contributes to a risk of familial pulmonary arterial hypertension. Higasa K; Ogawa A; Terao C; Shimizu M; Kosugi S; Yamada R; Date H; Matsubara H; Matsuda F BMC Pulm Med; 2017 Apr; 17(1):57. PubMed ID: 28388887 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of Excessive Cell Proliferation by Calcilytics in Idiopathic Pulmonary Arterial Hypertension. Yamamura A; Ohara N; Tsukamoto K PLoS One; 2015; 10(9):e0138384. PubMed ID: 26375676 [TBL] [Abstract][Full Text] [Related]
20. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension. Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]